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Objectives The aim of this study was to test the hypothesis that 2 common polymorphisms in the chromosome 4q25 re-
gion that have been associated with atrial fibrillation (AF) contribute to the variable penetrance of familial AF.
Background Although mutations in ion channels, gap junction proteins, and signaling molecules have been described for
Mendelian forms of AF, penetrance is highly variable. Recent studies have consistently identified 2 common
single-nucleotide polymorphisms in the chromosome 4q25 region as independent AF susceptibility alleles.
Methods Eleven families in which AF was present in 2 members who also shared a candidate gene mutation were stud-
ied. These mutations were identified in all subjects with familial lone AF (n  33) as well as apparently unaf-
fected family members (age 50 years with no AF; n  17).
Results Mutations were identified in SCN5A (n  6), NPPA (n  2), KCNQ1 (n  1), KCNA5 (n  1), and NKX2.5 (n  1).
In genetic association analyses, unstratified and stratified according to age of onset of AF and unaffected age
50 years, there was a highly statistically significant association between the presence of both common
(rs2200733 and rs10033464) and rare variants and AF (unstratified p  1  108, stratified [age of onset 50
years and unaffected age 50 years] p  7.6  105) (unstratified p  0.0001, stratified [age of onset 50
years and unaffected age 50 years] p  0.0001). Genetic association analyses showed that the presence of
common 4q25 risk alleles predicted whether carriers of rare mutations developed AF (p  2.2  104).
Conclusions Common AF-associated 4q25 polymorphisms modify the clinical expression of latent cardiac ion channel and
signaling molecule gene mutations associated with familial AF. These findings support the idea that the genetic
architecture of AF is complex and includes both rare and common genetic variants. (J Am Coll Cardiol 2012;
60:1173–81) © 2012 by the American College of Cardiology Foundation
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.04.030T
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hAtrial fibrillation (AF) is an important and increasing public
health problem. The prevalence of AF doubles for each
advancing decade of life, and there is widespread agreement
that the prevalence is increasing over time (1,2). The risk
factors for AF are multifactorial and include male sex,
advancing age, coronary artery disease, congestive heart
failure, and valvular heart disease. However, a substantial
portion of the variability in risk for AF remains unexplained,
leading investigators to search for genetic factors.
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2012, accepted April 23, 2012.Investigators at the Framingham Heart Study have ob-
served that the odds ratio (OR) of developing AF was 1.8
times higher for subjects with at least 1 parent diagnosed with
AF compared with those without such a parental history (3).
he OR increased further (to 3.2) if 1 parent was affected
efore 75 years of age. In a population-based cohort of more
See page 1184
than 5,000 patients with AF from Iceland, first-degree relatives
of patients with AF were 1.77-fold more likely to have AF
than the general population, with a relative risk of 4.67 in
first-degree relatives of patients 60 years of age (4). Familial
ggregation of AF is particularly prominent in patients with
diopathic or so-called lone AF (i.e., early-onset AF without
tructural heart disease), for which as many as 30% of probands
ave first-degree relatives with the arrhythmia (5–7).
Although a Mendelian pattern of inheritance has beeneported, large AF kindreds such as those used to identify
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arrhythmia syndromes (e.g., con-
genital long-QT syndrome) are
unusual. A common presentation
of the Mendelian form of the
arrhythmia is a proband with fa-
milial lone AF (6). Mutations in
genes encoding cardiac ion chan-
nels, gap junction proteins, atrial
natriuretic peptide and nucleo-
porins (Nup155) have been reported in isolated cases and
small kindreds (8). Although traditional linkage analysis and
candidate gene approaches have been successful in identi-
fying monogenic forms of familial lone AF, the mode of
transmission for most forms of AF remains unclear, sup-
porting the idea that AF inheritance is complex.
In 2007, a genome-wide association study in Icelanders
identified a locus on chromosome 4q25 associated with AF
in subjects of all ages (9). Within this locus, 2 noncoding
single-nucleotide polymorphisms (SNPs) were indepen-
dently associated with AF, and these findings were repli-
cated in 2 populations of European descent and 1 of Asian
descent. The SNP most strongly associated with AF,
rs2200733, conferred a 1.71-fold increased risk for AF,
while the other SNP, rs10033464, conferred a 1.42-fold
increased risk. Recently, this association was replicated in a
study of 4 large populations with ambulatory AF (10). This
association has also been reported for post-cardiac surgery
AF, a setting thought to be related to inflammation (11),
and has recently been reported to predict the likelihood of
successful AF ablation (12). Although mutations in ion
channels, gap junction proteins, and signaling molecules
have been identified in isolated kindreds with 2 or more
members affected with familial lone AF, penetrance in these
families is highly variable. One potential explanation for this
phenomenon is the coexistence of modifier gene alleles,
possibly common SNPs altering AF susceptibility. In this
study, we tested the hypothesis that 4q25 genotypes con-
tribute to the variable penetrance of the AF phenotype in
familial AF.
Methods
Vanderbilt AF Registry. Between November 2002 and
uly 2009, subjects with AF were prospectively enrolled in
he Vanderbilt AF Registry, which comprises clinical and
enetic databases (13). At enrollment, detailed medical and
rug histories were obtained from all patients; patients were
lso asked to complete a symptom questionnaire. Patients
ere recruited from the Vanderbilt Cardiology and Ar-
hythmia Clinics, the emergency department, and inpatient
ervices. Echocardiography was performed in all patients at
he time of enrollment into the registry. The upper limits of
ormal for cardiac chamber dimensions are based on age
nd body surface area. Subjects 18 years of age with
Abbreviations
and Acronyms
AF  atrial fibrillation
DNA  deoxyribonucleic
acid
OR  odds ratio
SNP  single nucleotide
polymorphismdiagnoses of AF confirmed by electrocardiography whopresented because of symptoms or who were diagnosed
during routine physical examinations were included in the
Vanderbilt AF Registry. Subjects were excluded if AF was
diagnosed in the setting of recent cardiac surgery or if they
were unable to give informed consent or report for follow-
up. The study protocol was approved by the Vanderbilt
University institutional review board, and participants were
enrolled after providing written informed consent.
AF probands and their relatives were clinically classified
by a consistently applied set of definitions. AF was defined
as the replacement of sinus P waves by rapid oscillations or
fibrillatory waves that varied in size, shape, and timing and
were associated with an irregular ventricular response when
atrioventricular conduction was intact. Documentation of
AF on electrocardiography, rhythm strip, event recorder, or
Holter monitor recording was necessary. Paroxysmal AF
was defined as AF lasting more than 30 s that terminated
spontaneously. Persistent AF was defined as AF lasting
more than 7 days and requiring either pharmacologic
therapy or electrical cardioversion for termination. AF that
was refractory to cardioversion or that was allowed to
continue was classified as permanent.
Study cohort. The relationship between clinical phenotype
(familial lone AF) and genotype was determined for pro-
bands in whom ion channel and other gene mutations were
identified, together with their relatives. A total of 70
subjects in 11 kindreds had complete phenotype and geno-
type data available for analysis (Table 1), and this group
formed the study cohort.
Clinical phenotype. The clinical phenotype evaluated in
this study was lone familial AF, defined as AF occurring in
patients 66 years of age without hypertension, overt
structural heart disease, or thyroid dysfunction (as deter-
mined by clinical examination, electrocardiography, echo-
cardiography, and normal thyroid function test results) and
AF in 1 or more first-degree relatives (5,6). Left ventricular
hypertrophy was defined as a left ventricular mass index
150 g/m2 (14). All familial lone AF probands had left
ventricular mass indexes 150 g/m2.
Familial AF was defined as the presence of AF in 1 or
more first-degree relatives of the index case. Although the
proband in each family had to have lone AF, other family
members were classified as affected if they had AF, despite
structural heart disease. Family history information was
initially obtained from the medical record and was supple-
mented by a questionnaire detailing medical history, family
history, and clinical symptoms. For lone AF probands with
positive family histories, family members were contacted,
and more detailed personal medical histories were obtained.
Family members were then sent a blood kit for deoxyribo-
nucleic acid (DNA) extraction, and written permission was
obtained to review their medical records. We routinely
evaluate for the presence of asymptomatic AF by providing
all unaffected family members who consent to participate in
the study with a 7-day full-disclosure continuous monitor.
In addition, individuals with symptoms suggestive for AF
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September 25, 2012:1173–81 Modifier Genes for Familial AFare also given a 30-day event recorder that can be activated
whenever they develop symptoms.
Screening for mutations in ion channel and other genes.
Whole blood was collected for genomic DNA extraction
and analysis from lone AF probands and as many first-
degree relatives as would consent to the study. Mutational
Clinical Characteristics of Familial Lone AF ProbVa derbilt AF R g ry Identified to Have MutatIon Channel or Si naling Proteins
Table 1
Clinical Charac eristics f Familial
Vanderbilt AF Registry Identified to
Ion Channel or Signaling Proteins
AF Kindred and
Pedigree #
Age at Onset
(yrs)
Age at Diagnosis
(yrs)
AF027
II-1 41 54
III-1 31 36
AF063
II-1 33 39
II-2 41 48
AF119
I-1 51 54
II-1 28 38
AF240
II-1 70 72
III-1 42 42
III-2 39 42
AF527
I-1 52 54
II-1 56 56
III-1 17 25
AF313
II-1 48 56
II-1 44 46
II-2 42 43
II-4 44 45
AF579
I-1 56 64
II-2 48 49
II-3 49 50
AF673
II-1 48 50
AF242
II-1 38 40
II-9 42 44
III-2 20 26
AF406
I-1 78 78
II-4 61 62
II-5 52 58
III-1 17 22
III-3 39 42
III-5 42 46
III-7 44 45
AF1111
I-1 58 64
II-4 56 60
II-5 46 48
AF  atrial fibrillation; LA  left atrial; LVH  left ventricular hypertrop
persistent atrial fibrillation; PermAF  permanent atrial fibrillation.analyses of SCN5A (15), KCNQ1 (16), NPPA (16), KCNA5 a17), and NKX2.5 genes were performed in lone AF
robands and all consented family members. The coding
nd flanking regions were amplified by polymerase chain
eaction using primers designed to obtain fragments of
ppropriate size, as previously described (15–17). Briefly,
olymerase chain reaction–amplified DNA fragments were
Enrolled in theor Rare Variants inAF Probands Enrolled in the
Mutations or Rare Variants in
ythm Symptoms Echocardiography
LA Size
(mm)
rstAF Yes LVH 46
F Yes Normal 42
F Yes Normal 44
F Yes Normal 42
rstAF No Normal 46
F Yes Normal 42
rstAF No LVH 50
F Yes Normal 43
F Yes Normal 42
rstAF Yes LVH 46
F Yes Normal 44
F Yes Normal 42
rmAF Yes MR, LVH 52
rstAF Yes Normal 42
F Yes Normal 41
F Yes Normal 42
rstAF No LVH 46
F Yes Normal 43
F No Normal 41
F Yes Normal 41
F Yes Normal 44
F Yes Normal 43
F Yes Normal 39
rmAF No LVH 48
rstAF No LVH 49
F Yes Normal 46
F Yes Normal 39
F Yes Normal 42
F Yes Normal 44
F Yes Normal 46
rmAF No LVH 50
F Yes Normal 44
F Yes Normal 45
 mitral regurgitation; PAF  paroxysmal atrial fibrillation; PerstAF andsio sL e
Have
Rh
Pe
PA
PA
PA
Pe
PA
Pe
PA
PA
Pe
PA
PA
Pe
Pe
PA
PA
Pe
PA
PA
PA
PA
PA
PA
Pe
Pe
PA
PA
PA
PA
PA
Pe
PA
PAnalyzed using the Reveal Discovery System (based on
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Modifier Genes for Familial AF September 25, 2012:1173–81temperature gradient capillary electrophoresis) to identify
aberrant conformers, which were then directly sequenced.
Table 2 lists the number of lone and typical (non-lone)
patients with AF enrolled in the Vanderbilt AF Registry
and controls who were screened for genetic variants in the
ion channel and non–ion channel genes.
q25 genotypes. Genotyping of the 2 SNPs (rs2200733 and
s10033464) was performed using real-time polymerase
hain reaction, iPLEX single base primer extension, and
atrix-assisted laser desorption/ionization time-of-flight
ass spectrometry in a 384-well format (Sequenom, San
iego, California) as previously described (18). Seventy
ubjects (11 familial lone AF probands and 69 family
embers) underwent genotyping at the 2 common 4q25
NPs.
tatistical analysis. The goal of these analyses was to
etermine if there is a statistically significant association
etween the presence of both common and rare AF variants
nd the development of AF (i.e., AF disease status). We
ypothesized that the common variants on 4q25 influence
he development of AF by modulating the rare ion channel
nd non–ion channel mutations. To test this hypothesis, we
rst performed a series of chi-square tests (2  2 tables) of
ssociation (using Yates’s correction test for small sample
ize) with 1 degree of freedom. We initially performed an
nstratified analysis, followed by 5 stratified analyses on the
asis of the age at onset of AF and the age of the controls.
ecause most lone AF probands develop AF before the age
f 50 years, our first age cutoff for AF age of onset was 50
ears, but we also stratified on the basis of an AF age of
nset of 40 years. Thus, we stratified by AF age at onset
50 years, AF age at onset 40 years, unaffected subjects
ge 50 years only, and the 2 possible combinations of
hese 3 criteria. We collapsed the common variant geno-
ypes into an allelic test of the presence and absence of the
ariant allele. The nominal p values as well as p values
enerated with permutation testing were determined.
Permutation testing was performed to correct for multiple
esting, while controlling for the familial relationships in the
Probands With AF Enrolled in the Vanderbilt AFRegistry (Cases) and Controls Who Weresequenced for Variants in Ion Ch n l andNon–Ion Ch nnel Ge es
Table 2
Probands With AF Enrolled in the Vanderbilt AF
Registry (Cases) and Controls Who Were
Resequenced for Variants in Ion Channel and
Non–Ion Channel Genes
Gene Lone AF Cases Controls
SCN5A 118 460
257 (typical AF)
KCNQ1 231 500
NPPA 98 500
133 (typical AF)
KCNA5 231 300
200 (typical AF)
NKX2.5 160 500
AF  atrial fibrillation.indreds. The process involved removing the AF affectiontatus within each family and randomly reassigning in the
ame proportion of affected and unaffected individuals. This
as carried out in each family, 1,000 times, to create 1,000
ull datasets. In each random dataset, we performed asso-
iation analysis and recorded the chi-square statistic. After
,000 analyses, we had an empirical distribution from which
o assign a permutation p value, which is adjusted for the
elatedness in the dataset. In addition, we performed the
nalyses by way of the presence or absence of rare variants
ignoring the common variant).
As a follow-up, we performed a second series of chi-
quare analyses (using Yates’s correction as appropriate).
ere, we restricted the dataset to include only those subjects
ho possessed a rare variant in the ion channel or non–ion
hannel genes sequenced; these analyses included 48 sub-
ects. In this set, we performed the identical series of
hi-square analyses as described previously, although here,
e were looking at the association of the common variant
ith AF status; all subjects possessed a rare variant in this
et. We performed the unstratified analysis first, followed by
stratified analyses. We again stratified by AF age at onset
50 years, AF age at onset 40 years, unaffected individ-
als age 50 years only, and the two possible combinations
f those 3 criteria. All chi-square tests of association were
erformed in JMP version 8.0 (SAS Institute Inc., Cary,
orth Carolina).
esults
tudy cohort. Our candidate gene approach to identifying
ovel mutations or rare variants associated with AF identi-
ed 11 familial lone AF probands who had 1 or more
rst-degree relatives with the arrhythmia. The total study
ohort consisted of 70 subjects in 11 kindreds who had
omplete phenotype and genotype data available for analysis
Table 2).
ovel SCN5A variants. During the initial 3-year enroll-
ent period, 396 patients with AF were approached, and
75 (95%) agreed to participate in the Vanderbilt AF
egistry (15). Within this cohort, 118 patients (31%) had
amilial lone AF. As previously reported, resequencing
dentified 8 novel variants in 10 probands (2.7%) that were
ot found in the population-based controls (0%) (p  .001)
15). Genotyping was performed in 6 of these kindreds with
or more affected subjects with AF (Fig. 1). The novel
ariants identified affect highly conserved residues in the
CN5A protein. All probands identified were heterozygous
or the mutation.
CNQ1 variant. In this study cohort of 231 subjects with
amilial lone AF, screening for KCNQ1 mutations in
genomic DNA identified a unique sequence variant in 1
case of familial AF (AF313) (16). In the proband, a 9-bp
duplication resulting in insertion of the amino acids isoleu-
cine, alanine, and proline at locations 54 to 56 (IAP54-56)
in the N-terminus of the KCNQ1 protein was identified.
The variant was also confirmed in 3 affected family mem-
A
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September 25, 2012:1173–81 Modifier Genes for Familial AFbers. The sequence change was not found in Caucasian,
Han Chinese, or Asian population controls but was identi-
fied in 2.1% (2 of 94) of African American subjects. Because
the controls were obtained from the anonymous Coriell
repository, no clinical information about these subjects is
available.
NPPA variants. Genomic DNA sequencing of NPPA
identified 2 novel missense mutations in 2 Caucasian AF
kindreds; S64R in AF1111 (16) and A117V in AF673
(Fig. 1). The S64R mutation was also confirmed in 2
affected family members but was absent in unaffected family
members. Furthermore, both mutations were not identified
in Caucasian, Han Chinese, Asian, or African American
population controls. The A117V mutation was identified in
a family with lone AF (Fig. 1). The kindred included 6
family members, 3 of whom were heterozygous for the
mutation, with the proband presenting with early-onset
Figure 1 Pedigrees of 12 Familial AF Kindreds With Rare Ion C
Squares indicate male family members, circles indicate female family members, a
bands. Solid symbols indicate the presence of atrial fibrillation (AF), and open sym
variant is indicated for persons with deoxyribonucleic acid samples available for te
single-nucleotide polymorphisms on chromosome 4q25 that been associated withparoxysmal lone AF. (KCNA5 variant. We resequenced KCNA5 in 231 subjects
with familial lone AF and identified a novel 33-bp coding
region deletion in 2 Caucasian probands with early-onset
lone AF. The variant results in the deletion of 11 amino
acids at positions 71 to 81 of the N-terminus (71-81del)
(17). The sequence change was not found in 200 patients
with typical AF and 300 ethnically matched population
controls. The proband in this kindred (AF579) presented
with symptomatic paroxysmal familial lone AF, and his AF
is currently managed with sotalol. A family history also
showed that most of the affected family members developed
familial lone AF at relatively young ages, and most pre-
sented with symptomatic paroxysmal AF.
NKX2.5 variant. NKX2.5 was screened in 160 familial lone
F patients. We identified 1 novel nonsynonymous variant
F145S) that was not identified in more than 300 control
atients with no history of AF. The proband in this kindred
el and Signaling Molecule Variants
bols with slashes indicate deceased family members. Arrows indicate the pro-
ndicate unaffected family members. The presence () or absence () of a rare
Numerals 1 (rs10033464) and 2 (rs2200733) refer to the genotype for the
 genotype not available.hann
nd sym
bols i
sting.
AF. NAAF027) presented with early-onset symptomatic familial
M
h
f
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Modifier Genes for Familial AF September 25, 2012:1173–81lone paroxysmal AF. The proband’s father also presented
with familial lone AF in his 40s, and his brother, who
carries the variant, has not been diagnosed with AF at age
52 years.
4q25 genotypes. Table 3 shows a significant interaction
between common and rare genetic variants on the basis of
an AF age of onset 50 years. However, when we stratified
on the basis of AF age of onset 40 years and the ages of
unaffected subjects in the families, there remained a signif-
icant association between the presence of common and rare
genetic variants (Table 4). Furthermore, when we examined
the genetic association of rare variants alone (ignoring
common variants) unstratified and stratified by age of onset
and the ages of unaffected subjects in the families, there
remained a highly statistically significant association be-
tween the presence of both common and rare variants and
AF disease status (Table 5). ORs were calculated for the test
of co-occurrence of rare and common variants, in the
unstratified and stratified analyses. The ORs ranged from 4
to 452 for the different strata; these values are far in excess
of the 1.4 to 1.7 reported for studies in the general
population, thus supporting the idea that these common
variants modulate penetrance of the AF phenotype in these
kindreds. ORs could not be calculated for the presence of
common variants in those subjects with rare variants only
because the contingency table cells contained zero counts.
We performed a logistic regression analysis with 2 main
effect terms (presence or absence of rare variants and presence
or absence of common variants) in addition to a multiplicative
interaction term (presence or absence of rare variants 
presence or absence of common variants). On the basis of
the likelihood ratio test, there was a highly significant
interaction (p  0.002).
An Interaction Between Rare (Ion Channel and Non–Ion Channel) and Common Genetic V riants toDetermi e Susceptibility to the Development fFamilial AF
Table 3
An Interaction Between Rare (Ion Channel and
Non–Ion Channel) and Common Genetic Variants to
Determine Susceptibility to the Development of
Familial AF
Chromosome 4q25 SNPs AF by Age 50 Years No AF by Age 50 Years
Absent 0 13
Present 21 8*
*p 1.21 105 comparing the presence of both common and rare variants in 11 kindreds with
amilial AF.
AF  atrial fibrillation; SNP  single-nucleotide polymorphism.
Genetic Association Between Common and Rare Variants Unstratifiand Stratified by Age of Onset and Age of Un ff cted Members ofTable 4 Genetic Association Betw e Common and Rare Variaand Stratified by Age of Onset and Age of Unaffected M
Stratification Sample Size
Unstratified 70
Age of onset 50 yrs 64
Age of onset 40 yrs 57
Unaffected age 50 yrs 48
Age of onset 50 yrs, unaffected age 50 yrs 42
Age of onset 40 yrs, unaffected age 50 yrs 35AF  atrial fibrillation; CI  confidence interval; OR  odds ratio.Discussion
The present findings provide strong evidence that 2 com-
mon AF-associated polymorphisms act as genetic modifiers
of the clinical expression of latent cardiac ion channel and
signaling gene mutations associated with familial AF. Fur-
thermore, our findings strongly support the idea that AF
inheritance is complex and non-Mendelian.
Although the potential mechanism of action of variants at
the chromosome 4q25 locus tagged by the 2 noncoding
SNPs remains unknown, it is quite likely mediated through
effects on the paired-like homeodomain transcription factor 2
(PITX2) gene. PITX2 plays a critical role in left-right
asymmetry, and loss of the pitx2c isoform in mice can lead
to right atrial isomerization and failure to suppress a default
pathway for sinus node development of the pulmonary
myocardium (19–21). Importantly, this area is now well
recognized as a common source for ectopic atrial activity
necessary for the initiation and propagation of AF (22).
icroarray analysis of pitx2 null-mutant and control mice
earts has revealed up-regulation of Kcnq1, a potassium
channel gene that has been associated with gain-of-function
mutations in familial AF (19,20). More recently, Kirchhof
et al. (23) performed expression arrays in pitx2/ mice
demonstrating alteration in a number of cellular and mo-
lecular pathways in addition to potassium channels, which
might provide an explanation for why mutations in ion
channels are associated with familial AF. These recent data
strongly support our hypothesis that the 4q25 AF suscep-
tibility alleles likely mediate their effects by the modulation
of cardiac ion channel expression and signaling proteins in
the heart.
Investigating the genetic basis for AF presents a number
of important challenges (8). The paroxysmal nature and
variable symptoms in AF, a high prevalence in the general
population, and a late age of onset in many patients all make
assignment of the correct clinical phenotype challenging.
This complexity has compelled a search for new, more
effective methods for investigating the genetics of AF. One
approach is to use the families of affected patients as an
enriched target population for the definition and evaluation
of intermediate or endophenotypes, such as prolonged
signal-averaged P-wave duration (24), which are causally
related to the poorly penetrant classic clinical syndromes
amiliesnstratified
ers of the Families
sence of Both Common and
Rare Variants (p Value) OR (95% CI)
Permutation
p Value
9.21  1010 53 (10–273) 0.001
9.41  108 39 (8–205) 0.001
4.13  106 51 (6–452) 0.001
8.63  107 41 (7–239) 0.001
1.21  105 31 (5–179) 0.001
1.62  104 40 (4–385) 0.001edthe Fnts U
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apply other approaches to identify genes that may be
associated with AF. A logical consequence of the availability
of comprehensive genomic maps is the advent of high-
density genome-wide searches for modest gene effects using
large-scale testing of SNPs. This approach has identified
common variants on the chromosome 4q25 locus and more
recently common SNPs on chromosomes 16q22 (26) and
1q21 (27) that confer an increased risk (OR: 1.2 to 1.4) for
AF across multiple different populations.
One of the most challenging problems with non-
Mendelian genetic approaches is the differentiation of signal
from noise. Association studies may be confounded by
etiologic heterogeneity, population stratification, or false-
positives, while the bias toward small effects may miss major
genetic contributions relevant only in a subset of study
subjects. It may also prove difficult to define the fundamen-
tal mechanisms of any true associations, because the respon-
sible gene may be remotely linked to the locus identified.
The development of more efficient models for the rapid
validation of genomewide association study results and
improved understanding of the underlying biology will
facilitate the interpretation of such studies. In our study,
however, variants identified in our screening are likely to
be causative, because we demonstrated cosegregation of
the variants with AF in multiple kindreds (where avail-
able), the variants were absent in a large control popula-
tion, and all novel variants are located in highly conserved
regions of the ion channel and signaling protein. This
supports a link between disturbed ion channel and
protein function and AF.
Studies of kindreds with AF suggest a genetic basis for
the condition, and mutations in several cardiac potassium
channel genes have been linked to familial AF (28,29).
Although specific mutations in the KCNQ1 gene have been
bserved in families with AF, the role of such mutations in
F remains unclear; often such isolated or “private” muta-
ions are in residues of unknown function, effects on channel
onductance are variable, and in most cases it may be
ifficult to discriminate rare polymorphisms of no functional
ignificance from true mutations. However, the low preva-
ence of KCNQ1 mutations in large AF cohorts suggests
Genetic Association of Rare Variants Alone (Ignorand Stratified by Age of Onset d Age of UnaffTable 5 Genetic Association of Rar Varia tsand Stratified by Age of Onset and
Stratification Sa
Unstratified
Age of onset 50yrs
Age of onset 40 yrs
Unaffected age 50 yrs
Age of onset 50 yrs, unaffected age 50 yrs
Age of onset 40 yrs, unaffected age 50 yrs
Abbreviations as in Table 4.hat mutations in this gene are not a major cause of AF(30,31). In AF313, multiple family members presented with
early-onset lone AF, and our segregation analysis supports
the novel KCNQ1 mutation as being causative for AF.
Furthermore, the absence of the KCNQ1 variant (IAP54-56) in
non–African-American control groups excludes the possi-
bility that this mutation is a common polymorphism in this
population; this finding is consistent with a disease-
associated mutation. The KCNQ1–IAP54-56 variant, how-
ever, was identified in 2.1% of healthy African American
subjects, suggesting that it may be a common risk allele in
this population.
Several limitations of the present study warrant consid-
eration. First, most of the AF kindreds were small, and
therefore, formal segregation analysis was limited. Data for
some unaffected family members were not available. Second,
no novel mutations were identified in the ethnically defined
controls. However, comprehensive resequencing of the in-
dividual gene in the population-based controls was not
performed, and this may condition interpretation of the
results of this study. Although it is possible that additional
novel ion channel and other gene mutations may have been
identified, and our focused strategy of control genotyping
may underestimate the true prevalence of rare polymor-
phisms, the association of the mutations with AF is sup-
ported primarily by segregation analysis and the fact that the
mutations occurred in a highly conserved region of the
protein. Third, population stratification may confound our
results, especially across families. However, because our
ommon Variants) UnstratifiedMembers of he Familiese (Ignoring Commo Var ants) Unstratified
f Unaffected Members of the Families
ize
Presence/Absence
of Rare Variants Only
(p Value) OR (95% CI)
2.2 104 19 (2.4–155)
0.003 14 (1.7–117)
0.04 8.8 (1.1–74)
2.1 104 26 (3.0–227)
0.002 20 (2.2–173)
0.013 12 (1.3–109)
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Table 6
Genetic Association of Common Variants in the
Subset of Data With All Subjects Harboring Rare
Variants: Unstratified and Stratified by Age of Onset
and Age of Unaffected Members of the Families
Stratification
Sample
Size
Common Variants in Subjects
With Rare Variants Only
(p Value)
Unstratified 48 2.79 107
Age of onset 50 yrs 42 4.41 106
Age of onset 40 yrs 36 1.46 104
Unaffected age 50 yrs 34 3.4  104
Age of onset 50 yrs,
unaffected age 50 yrs
28 0.001
Age of onset 40 yrs, 22 0.01ing CectedAlon
Age o
mple S
70
64
57
48
42
35unaffected age 50 yrs
c
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1
1
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Modifier Genes for Familial AF September 25, 2012:1173–81cohort came from a fairly homogenous population of indi-
viduals of European descent, we believe that this is unlikely
to bias our results. Furthermore, data on the common 4q25
allele frequencies (as shown in Table 7) would suggest
otherwise.
Clinical implications. The idea that a combination of
ommon and rare variants contributes to the very common
henotype of AF may have significant impact on the
ssessment and management of patients not only with
amilial AF but also the more common forms of the
rrhythmia. Our study has demonstrated that the pen-
trance of genes encoding rare ion channel and signaling
roteins is modulated by common variants on chromosome
q25, supporting the idea that AF inheritance is complex
i.e., a single genetic variant does not predict the pheno-
ype). Currently there is no clinical role for genetic testing in
ost patients with AF (32). However, a case can be made to
creen candidate AF genes in those patients who present
ith early-onset lone AF, especially if there is a strong
amily history of the arrhythmia. Identification of a rare
enetic variant in lone AF probands may be followed by
onsideration of screening family members to identify other
arriers and also genotyping at the 4q25 AF locus. Identi-
cation of family members who are at risk for developing
F is important, because therapies known to reduce the
ncidence of AF, such as angiotensin-converting enzyme
nhibitors, could be considered.
onclusions
e have shown that 2 common AF-associated polymor-
hisms can act as genetic modifiers of the clinical severity
f familial AF. One interpretation of our findings is that
n kindreds with familial AF, the arrhythmia develops in
ubjects who have the rare AF-associated variants as well
s susceptibility alleles determined by the 4q25 locus. Our
ndings support the general concept that common variants
ay act as significant modifiers of the effects of rare variants
nd that the genetic architecture of common human pheno-
ypes includes both rare and common variants (33).
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llele Frequencies of Chromosomeq25 Single-Nucleotide P lym rphisms
Table 7 Allel Frequencie of Chromosome4q25 Single-Nucleotide Polymorphisms
Variant Genotype Number of Alleles Allele Frequency
rs10033464 C 22 0.16
G 114 0.83
T 2 0.01
rs2200733 C 114 0.83
T 24 0.17vanderbilt.edu.REFERENCES
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